METTL3 is shown to be highly explored in advanced acute myeloid leukemia (AML) and has reported roles in lung cancer and HCC (Lin et al., 2016; Vu et al., 2017; Chen et al., 2018). This evidence concerns the gene METTL3 and hepatocellular carcinoma.